The Pediatric Stem Cell Research Institute, Edmond and Lily Safra Children's Hospital, Sheba Center for Regenerative Medicine, Sheba Medical Center, Ramat-Gan, Israel.
EMBO Mol Med. 2013 Oct;5(10):1556-68. doi: 10.1002/emmm.201201584. Epub 2013 Sep 2.
Identification of tissue-specific renal stem/progenitor cells with nephrogenic potential is a critical step in developing cell-based therapies for renal disease. In the human kidney, stem/progenitor cells are induced into the nephrogenic pathway to form nephrons until the 34 week of gestation, and no equivalent cell types can be traced in the adult kidney. Human nephron progenitor cells (hNPCs) have yet to be isolated. Here we show that growth of human foetal kidneys in serum-free defined conditions and prospective isolation of NCAM1(+) cells selects for nephron lineage that includes the SIX2-positive cap mesenchyme cells identifying a mitotically active population with in vitro clonogenic and stem/progenitor properties. After transplantation in the chick embryo, these cells-but not differentiated counterparts-efficiently formed various nephron tubule types. hNPCs engrafted and integrated in diseased murine kidneys and treatment of renal failure in the 5/6 nephrectomy kidney injury model had beneficial effects on renal function halting disease progression. These findings constitute the first definition of an intrinsic nephron precursor population, with major potential for cell-based therapeutic strategies and modelling of kidney disease.
鉴定具有肾发生潜力的组织特异性肾干/祖细胞是开发基于细胞的肾脏疾病治疗方法的关键步骤。在人类肾脏中,干细胞/祖细胞被诱导进入肾发生途径形成肾单位,直到妊娠 34 周,而在成人肾脏中无法追踪到等效的细胞类型。尚未分离出人类肾祖细胞(hNPC)。在这里,我们表明,在无血清定义条件下生长的人类胎儿肾脏和 NCAM1(+)细胞的前瞻性分离选择了包括 SIX2 阳性帽间充质细胞的肾系,鉴定出具有体外克隆形成和干/祖细胞特性的有丝分裂活性群体。在鸡胚中移植后,这些细胞 - 而不是分化的对应物 - 有效地形成了各种肾单位管类型。hNPC 移植并整合在患病的小鼠肾脏中,并且在 5/6 肾切除术肾损伤模型中的肾衰竭治疗对肾功能具有有益的影响,阻止了疾病的进展。这些发现构成了内在肾前体细胞群的第一个定义,具有基于细胞的治疗策略和肾脏疾病建模的主要潜力。